Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07161648 · ClinicalTrials.gov registry record · NA
Use of Neuromuscular Electrical Stimulation to Prevent Exercise Resistance
A NA study of Fat Metabolism, sponsored by Colorado State University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07161648: Recruiting NA study of Fat Metabolism, sponsored by Colorado State University.
NCT07161648 is a NA study of Fat Metabolism that is actively recruiting participants, run by Colorado State University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07161648, a NA study of Fat Metabolism, is actively recruiting participants, sponsored by Colorado State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will find out if 100 minutes of electrical stimulation of muscle prevents the unfavorable consequence of insufficient exercise.
Primary Outcome
Circulating triglyceride concentration after eating a high fat meal.
Conditions Studied
Interventions
- OTHER neuromuscular electrical stimulation
Study Locations (1)
Colorado
- Colorado State University - Fort Collins
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-10-17 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What NCT07161648 shows while recruiting
NCT07161648 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Fat Metabolism appearing as the primary indexed condition, and to 1 intervention - of which neuromuscular electrical stimulation is the first listed.
NCT07161648 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT07161648 about?
NCT07161648 is a clinical study titled "Use of Neuromuscular Electrical Stimulation to Prevent Exercise Resistance". The study will find out if 100 minutes of electrical stimulation of muscle prevents the unfavorable consequence of insufficient exercise.
What is the current status of trial NCT07161648?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-10-17. Estimated completion is 2026-09-30.
What conditions does trial NCT07161648 study?
This clinical trial studies the following conditions: Fat Metabolism.
What interventions are being tested in trial NCT07161648?
The interventions under investigation include: neuromuscular electrical stimulation (OTHER).
Who is sponsoring clinical trial NCT07161648?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07161648 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07161648's enrollment target sits among peer trials
30 1594th of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI